Nordic Capital to partner with Evosep, a leader in proteomics technologies for the global life science industry
Nordic Capital today announced an agreement to become the majority owner in Evosep, a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. The investment, leveraging Nordic Capital's experience as a leading investor in healthcare and life science for over 30 years, will be made in close collaboration with Evosep's founders and […]